西班牙获得性血友病A注册研究:管理现状与结局
The Spanish Acquired Hemophilia A (AHA) Registry is intended to update the status of AHA in Spain. One hundred and fifty-four patients were included and retrospectively followed for a median of 12 months.…
要点
- 诊断后2个月内感染死亡常见,既往抗血栓治疗与死亡率相关。
- 女性及高抑制物水平负向影响完全缓解。
核心结论
- 诊断后最初数月致命性感染常见,抗血栓治疗与死亡率相关,应特别注意避免误诊。
主要发现
- 患者以男性为主(56.3%),诊断中位年龄74岁,特发性占44.1%,自身免疫病相关占31.7%。
- 女性及高抑制物水平负向影响完全缓解。
临床怎么用
- 获得性血友病A应尽早识别避免误诊,尤其对接受抗血栓治疗者。
- 免疫抑制治疗中单用激素疗效较低,可考虑联合方案。
- 诊断后前2个月需警惕感染和出血导致的死亡。
局限性
- 回顾性注册研究,可能存在选择偏倚和信息偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Spanish Acquired Hemophilia A (AHA) Registry is intended to update the status of AHA in Spain. One hundred and fifty-four patients were included and retrospectively followed for a median of 12 months. Patients were predominantly male (56.3%), with median age at diagnosis of 74 years. AHA was more frequently idiopathic (44.1%) and autoimmune disorder-associated (31.7%). Thirty-four percent of patients were on antithrombotic therapy at diagnosis. Hemostatic treatment was used in 70% of patients. Recombinant activated factor VII was more frequently infused (60.3% vs 20.6% activated prothrombin complex concentrate). Only 1 patient did not achieve control of hemorrhage. Complete remission (CR) was achieved by 84.2% of cases after immunosuppressive therapy. Steroids alone were less efficient than the other strategies (68.2% vs 87.2%, P = .049), whereas no differences existed among these (steroids/cyclophosphamide, 88.5%, vs steroids/calcineurin inhibitors, 81.2%, vs rituximab-based regimens, 87.5%). Female sex and high inhibitor levels influenced CR negatively. Thirty-six deaths (23.8%) were reported. Main causes of death were infection (15 patients, 9.9%) and hemorrhage (5 patients, 3.3%). All hemorrhage-related and half the infection-related deaths occurred within 2 months of diagnosis. Prior antithrombotic therapy was inversely associated with survival, irrespective of age. Median age of nonsurvivors was significantly higher (79 vs 73 years in survivors). Patients dying of infection were older than the other nonsurvivors (85 vs 78 years). In summary, fatal infection in the first months is common in our series. Antithrombotic therapy is associated with mortality. Particular care should be taken to avoid misdiagnosis.
引用
- Mingot-Castellano ME, Pardos-Gea J, Haya S, et al. Management of acquired hemophilia A: results from the Spanish registry. Blood Adv. 2021. PMID: 34521101. doi:10.1182/bloodadvances.2021004626
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。